Poloxamer-407 (P-407) is a nonionic surfactant that induces atheroma format
ion in the aortas of C57BL/6 mice with long-term (14 weeks) administration.
The objectives of the present study were to determine the mechanism(s) res
ponsible for the induction of hypercholesterolemia as well as to determine
whether this animal model may be of potential use in rank ordering the effi
cacy (lipid lowering) of various statin drugs. The effect of long-term (16
weeks) administration of P-407 on the catalytic activities of rate-limiting
enzymes of cholesterol biosynthesis [HMG-CoA reductase (HMGR)] and catabol
ism [microsomal cholesterol 7 alpha -hydroxylase (C7 alphaH) and mitochondr
ial sterol 27 hydroxylase (S27H)] was assessed in C57BL/6 mice. Effects of
P-407 on these enzymes were compared in mice fed an atheroma-inducing diet
(high-cholesterol, supplemented with cholic acid) and animals maintained on
a basal diet and injected with saline (controls) after 16 weeks. The mean
value for the activities of C7 alphaH in P-407-injected mice was 24.3 +/- 3
.8 pmol min(-1) mg(-1) and was significantly (P < 0.05) less than the mean
value determined for sham-injected control animals (37.0 +/- 14.3 pmol min(
-1) mg(-1)). In contrast, the mean values for the catalytic activities of S
27H and HMGR did not change with P-407 administration. Neither C7 alphaH no
r S27H activity in mice fed the high-cholesterol diet differed from values
for control animals, whereas the mean HMGR activity was drastically reduced
(- 94%, P < 0.05). The hypercholesterolemic effect of P-407 is not due to
altered cholesterol biosynthesis, but is mediated by reduced cholesterol ca
tabolism due to decreased activity of the rate limiting enzyme (C7 alphaH)
in the classic bile acid synthetic pathway. Plasma triglyceride lowering re
sulting from the oral administration of equal doses of various statin drugs
appeared, in general, to be positively correlated with their relative aque
ous solubility and paralleled the efficacy of these agents to lower low-den
sity-lipoprotein-associated cholesterol (LDL-C) in humans. The plasma trigl
yceride lowering effect of the five statin drugs tested produced the follow
ing rank order; pravastatin sodium (- 44%) > atorvastatin calcium (- 36%) >
simvastatin (- 33%) > lovastatin (- 25%) > fluvastatin sodium (- 19%). Whi
le reductions in plasma total cholesterol following administration of the s
tatin drugs was not as profound as that observed with triglycerides, the re
lative rank order or trend was preserved. The percent reduction in plasma t
riglycerides in the present model appears to be a useful parameter with whi
ch to predict the relative reduction in plasma LDL-C expected for these age
nts in humans. (C) 2001 Elsevier Science B.V. All rights reserved.